These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19164151)

  • 1. Lack of allergic cross-reactivity between fluconazole and voriconazole.
    Pinto A; Chan RC
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1715-6. PubMed ID: 19164151
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactivity between voriconazole, fluconazole and itraconazole.
    Benjamin Lash D; Jolliff J; Munoz A; Heidari A
    J Clin Pharm Ther; 2016 Oct; 41(5):566-7. PubMed ID: 27430151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed drug eruption caused by itraconazole: Reactivity and cross reactivity.
    Gupta R; Thami GP
    J Am Acad Dermatol; 2008 Mar; 58(3):521-2. PubMed ID: 18280361
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of cross-hepatotoxicity between fluconazole and voriconazole.
    Spellberg B; Rieg G; Bayer A; Edwards JE
    Clin Infect Dis; 2003 Apr; 36(8):1091-3. PubMed ID: 12684933
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.
    Barry AL; Brown SD
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1948-9. PubMed ID: 8843312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern antifungals in therapy of nosocomial mycosis in oncologic patients].
    Mitrokhin SD; Sokolov AA
    Antibiot Khimioter; 2011; 56(1-2):29-34. PubMed ID: 21780669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
    Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
    Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
    Nguyen MH; Yu CY
    J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
    Ally R; Schürmann D; Kreisel W; Carosi G; Aguirrebengoa K; Dupont B; Hodges M; Troke P; Romero AJ;
    Clin Infect Dis; 2001 Nov; 33(9):1447-54. PubMed ID: 11577374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
    Chauhan N; Kruppa M; Calderone R
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3747-51. PubMed ID: 17664325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
    Burn AK; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; McCarthy DI; Rinaldi MG; Redding SW
    J Clin Microbiol; 2004 Dec; 42(12):5846-8. PubMed ID: 15583322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
    Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Monzón A; Rodríguez-Tudela JL
    Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):432-5. PubMed ID: 10442422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates.
    Nguyen MH; Yu CY
    Antimicrob Agents Chemother; 1998 Feb; 42(2):471-2. PubMed ID: 9527812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.
    Pfaller MA; Zhang J; Messer SA; Brandt ME; Hajjeh RA; Jessup CJ; Tumberland M; Mbidde EK; Ghannoum MA
    Antimicrob Agents Chemother; 1999 Jan; 43(1):169-71. PubMed ID: 9869586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
    Bagg J; Sweeney MP; Davies AN; Jackson MS; Brailsford S
    J Med Microbiol; 2005 Oct; 54(Pt 10):959-964. PubMed ID: 16157550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
    Heng SC; Slavin MA; Al-Badriyeh D; Kirsa S; Seymour JF; Grigg A; Thursky K; Bajel A; Nation RL; Kong DC
    J Antimicrob Chemother; 2013 Jul; 68(7):1669-78. PubMed ID: 23485723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes-like eruption due to fluconazole.
    González-Fernández T; López-Freire S; Juangorena M; Méndez-Brea P; Vázquez-Veiga H
    J Investig Allergol Clin Immunol; 2015; 25(2):135-6. PubMed ID: 25997308
    [No Abstract]   [Full Text] [Related]  

  • 20. Graded isavuconazole introduction in a patient with voriconazole allergy.
    Morales MK; Harris C; Shoham S
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28851131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.